Skip to main content

Vyome Holdings, Inc

HIND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001427570

No open-market purchases or sales by Vyome Holdings, Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $296.5K in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Vyome Holdings, Inc changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of HIND: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders1518+3
Shares1.05M660.5K−386.1K (−36.9%)
Value$5.23M$1.90M−$3.33M (−63.7%)

New holders (9)

Institutions that held Vyome Holdings, Inc at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to HIND in Q3 2021
InstitutionSharesValue% of portfolio
Price T Rowe Associates Inc135,700$391.0K0.00%
Susquehanna Fundamental Investments, LLC95,100$274.0K0.01%
Virtu Financial LLC71,681$206.0K0.02%
Two Sigma Investments, LP40,255$116.0K0.00%
XTX Topco Ltd26,951$78.0K0.03%
Mid Atlantic Financial Management Inc10,000$29.0K0.00%
Sassicaia Capital Advisers LLC10,000$29.0K0.08%
Bank of America Corp9,595$28.0K0.00%
Signaturefd, LLC8,000$23.0K0.00%

Sold out (6)

Institutions that held Vyome Holdings, Inc at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of HIND in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Armistice Capital, LLC816,527$4.08M
Jane Street Group, LLC24,188$121.0K
Alpine Global Management, LLC17,000$85.0K
Citigroup Inc167$1.00K
JPMorgan Chase & Co2$0
Salem Investment Counselors Inc4$0